Akebia Therapeutics (AKBA) Other Accumulated Expenses (2013 - 2020)
Akebia Therapeutics (AKBA) posted quarterly Other Accumulated Expenses of $2.5 million for Q1 2020, up 16.32% year-over-year from $2.1 million in Q2 2019, and down 74.25% quarter-over-quarter from $9.5 million in Q4 2019.
Akebia Therapeutics (AKBA) Other Accumulated Expenses (2013 - 2020) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Other Accumulated Expenses for 8 consecutive years, with $2.5 million the latest figure, recorded in Q1 2020.
- In Q1 2020, Other Accumulated Expenses rose 16.32% year-over-year to $2.5 million; the TTM figure through Mar 2020 stood at $2.5 million (up 16.32% YoY), while the FY2019 annual figure was $9.5 million, down 20.97% from the prior year.
- Other Accumulated Expenses fell to $2.5 million in Q1 2020 per AKBA's latest filing, from $9.5 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $12.8 million in Q2 2019 and bottomed at $1.3 million in Q1 2016.
- Historically, Other Accumulated Expenses has averaged $4.2 million across 5 years, with a median of $2.4 million in 2017.
- Annual changes were most pronounced in 2018 — Other Accumulated Expenses soared 410.0% — and 2019, when it tumbled 54.31%.
- Akebia Therapeutics' Other Accumulated Expenses stood at $1.9 million in 2016, then increased by 21.74% to $2.4 million in 2017, then jumped by 410.0% to $12.1 million in 2018, then slipped by 20.97% to $9.5 million in 2019, then sank by 74.25% to $2.5 million in 2020.
- Business Quant data shows AKBA's Other Accumulated Expenses at $2.5 million in Q1 2020, $9.5 million in Q4 2019, and $2.7 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Akebia Therapeutics | 247.98 Mn | 92.43 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 2.46 Mn |
| Dec 31, 2019 | 9.55 Mn |
| Sep 30, 2019 | 2.70 Mn |
| Jun 30, 2019 | 12.80 Mn |
| Mar 31, 2019 | 2.11 Mn |
| Dec 31, 2018 | 12.08 Mn |
| Sep 30, 2018 | 5.90 Mn |
| Jun 30, 2018 | 4.51 Mn |
| Mar 31, 2018 | 3.22 Mn |
| Dec 31, 2017 | 2.37 Mn |
| Sep 30, 2017 | 2.28 Mn |
| Jun 30, 2017 | 2.44 Mn |
| Mar 31, 2017 | 2.32 Mn |
| Dec 31, 2016 | 1.95 Mn |
| Sep 30, 2016 | 1.95 Mn |
| Jun 30, 2016 | 2.05 Mn |
| Mar 31, 2016 | 1.31 Mn |
| Dec 31, 2015 | 1.37 Mn |
| Sep 30, 2015 | 999,000.00 |
| Jun 30, 2015 | 596,000.00 |